Takeda enters the pharmaceutical league
The Japanese company entered the lucrative US market by the hand of Shire through the big door and, according to forecasts, it will make a record profit in 2021 thanks to treatments such as Entyvio or Vyvanse. The second half of the decade looks promising. The Japanese firm plans to launch 12 new treatments in […]